Abbott launches COVID-19 lab-based antibody test

Abbott has announced the immediate availability of its lab-based antibody test for COVID-19 after it was granted a CE Mark.

The test will identify if a person has had the novel COVID-19, and will further understanding of the virus including how long antibodies stay in the body and if they provide immunity.

According to Abbott, it has demonstrated specificity and sensitivity of greater than 99% 14 days or more after symptoms started.

The test adds to Abbott's existing COVID-19 tests in the UK that are already being used on its m2000 molecular laboratory system, which is already in use across NHS laboratories.

"We are proud to be able to provide our antibody tests immediately as they will help understand who has had the virus, leading to greater confidence as we get back to living life,” commented Mike Clayton, managing director Northern Europe diagnostics, Abbott.

“We are collaborating with the NHS, Public Health bodies and private laboratories across the UK to enable this test to be used here.”

CPhI China 2020 To Be Postponed to Dec. 16-18th,

Register as Visitor to the 20th Edition of CPhI China!

-----------------------------------------------------------------------
Editor's Note:

To become a freelance writer of PharmaSources.com,

welcome to send your CV and sample works to us,

Email: Julia.Zhang@imsinoexpo.com.